Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 135 citing Jeremias: Narrative review: alternative causes for elevated cardiac troponin levels when.... (0.12 sec) 

Prevalence and determinants of troponin T elevation in the general population

- ahajournals.org
TW Wallace, SM Abdullah, MH Drazner, SR … - Circulation, 2006 - Am Heart Assoc
Methods and Results— cTnT was measured from stored plasma samples in 3557
subjects of the Dallas Heart Study, a population-based sample. cTnT elevation (
0.01 µg/L) was correlated with clinical variables and cardiac MRI ...
Cited by 99 - Related articles - All 6 versions

Prognostic value of very low plasma concentrations of troponin T in patients with stable …

- ahajournals.org
R Latini, S Masson, IS Anand, E Missov, M … - Circulation, 2007 - Am Heart Assoc
From the Department of Cardiovascular Research, Istituto di Ricerche
Farmacologiche Mario Negri, Milan, Italy (RL, SM, LA, SB); Department of
Medicine, New York Medical College, Valhalla, NY (RL); Cardiology Section, ...
Cited by 73 - Related articles - All 8 versions

The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised …

- oxfordjournals.org
RG Assomull, JC Lyne, N Keenan, A Gulati, … - European Heart Journal, 2007 - Eur Soc Cardiology
Methods and results: Sixty consecutive patients (mean age 44 years, 72% male)
with a troponin-positive episode of chest pain and unobstructed coronary
arteries were recruited within 3 months of initial presentation. All ...
Cited by 40 - Related articles - BL Direct - All 3 versions

The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and …


AHB Wu, AS Jaffe - American Heart Journal, 2008 - Elsevier
Cardiac troponin is the biomarker of choice for the serologic diagnosis of acute
coronary syndromes. International cardiology and laboratory medicine guidelines
have suggested that the cutoff concentration be set at the 99th percentile ...
Cited by 32 - Related articles - All 20 versions

Relation between cardiac troponin I and mortality in acute decompensated heart failure


JJ You, PC Austin, DA Alter, DT Ko, JV Tu - American Heart Journal, 2007 - Elsevier
Cardiac troponin I levels >0.5 μg/L (median 1.7 μg/L, interquartile range
0.9-4.8 μg/L) occurred in 699 (34.5%) patients and was an independent predictor
of mortality (adjusted hazard ratio 1.49, 95% CI 1.25-1.77, P < .001). ...
Cited by 33 - Related articles - All 23 versions

Persistent cardiac troponin I elevation in stabilized patients after an episode of acute …

- ahajournals.org
KM Eggers, B Lagerqvist, P Venge, L … - Circulation, 2007 - Am Heart Assoc
Methods and Results— Cardiac troponin I (cTnI) was measured in 1092 stabilized
patients at 6 weeks and 3 and 6 months after enrollment in the FRagmin and Fast
Revascularization during InStability in Coronary artery disease (FRISC-II) ...
Cited by 30 - Related articles - All 5 versions

Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival …

- sphemerg.ca [PDF] 
R Alcalai, D Planer, A Culhaoglu, A Osman, A … - Archives of Internal Medicine, 2007 - Am Med Assoc
Results During the study period, 615 patients had elevated troponin T levels.
Only 326 patients (53%) received a main diagnosis of ACS, while 254 (41%) had
nonthrombotic troponin elevation; for 35 patients (6%), the diagnosis was ...
Cited by 25 - Related articles - BL Direct - All 6 versions

Elevated cardiac troponin measurements in critically ill patients


W Lim, I Qushmaq, PJ Devereaux, D Heels- … - Archives of Internal Medicine, 2006 - archinte.highwire.org
Methods Studies were identified using MEDLINE, EMBASE, and reference list
review. We included observational studies of critically ill patients that
measured cTn at least once and reported the frequency of elevated cTn or ...
Cited by 24 - Related articles - BL Direct - All 4 versions

Promise of New Vascular-Disrupting Agents Balanced With Cardiac Toxicity: Is It Time for …


WJ van Heeckeren, S Bhakta, J Ortiz, J … - Journal of Clinical Oncology, 2006 - jcojournal.org
Recently, VDAs have made the transition from preclinical in vivo laboratory
experiments to early-phase clinical trials in humans. Unlike the more well-known
antiangiogenic agents, such as the humanized monoclonal antibody ...
Cited by 19 - Related articles - All 6 versions

Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a …

- oxfordjournals.org
KM Eggers, L Lind, H Ahlstrom, T Bjerner, C … - European Heart Journal, 2008 - Eur Soc Cardiology
Methods and results: cTnI elevation defined as cTnI levels >0.01 µg/L (Access
AccuTnI, Beckman Coulter) was found in 21.8% of the study participants (n =
1005). cTnI > 0.01 µg/L was associated with cardiovascular high-risk ...
Cited by 14 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google